Organized by
Supported by
Daily Program
| May 9 (Fri) 09:15-09:45 |
Opening Ceremony *You can also view the Opening Ceremony in Room C (Emerald Room). |
Room A+B (Crystal Ballroom, 3F) |
|---|
| May 9 (Fri) 08:20-09:15 |
Updates, Treating Alzheimer's Disease with Monoclonal Antibodies**You can also view the session in Room C (Emerald Room). |
Room A+B (Crystal Ballroom, 3F) |
|---|---|---|
| Chairperson |
Seol-Heui Han (Konkuk University, Korea) Atsushi Iwata (Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan) |
|
| 08:20-08:35 |
Lecanemab Maintenance Dosing in Early Alzheimer's Disease: Support for Continued Dosing from Clinical, Pharmacology and Modeling Data
Larisa Reyderman (Eisai, USA) |
08:35-08:50 |
Relationship Between Amyloid Reduction and Clinical Outcomes Following Donanemab Therapy: Insights from the TRAILBLAZER-ALZ 2 Phase 3 Clinical Trial
Saygin Gonderten (Eli Lilly and Company, UAE) |
08:50-09:05 |
Update on Trontinemab, A Novel Brainshuttle Antibody in Development for the Treatment of Alzheimer’s Disease
Tobias Bittner (F.Hoffmann-LaRoche, Switzerland) |
09:05-09:15 |
Q & A
|
| May 9 (Fri) 09:45-10:25 |
Plenary Session 1 *You can also view the Plenary Session 1 in Room C (Emerald Room). |
Room A+B (Crystal Ballroom, 3F) |
|---|---|---|
| Chairperson | Jae-Hong Lee (University of Ulsan, Korea) | |
| 09:45-10:25 |
The Latest in Alzheimer’s and Dementia Science: A New Era of Research, Treatment and Care
Maria C. Carrillo (Alzheimer's Association, USA) |
|
| May 9 (Fri) 10:55-12:15 |
Plenary Session 2 *You can also view the Plenary Session 2 in Room C (Emerald Room). |
Room A+B (Crystal Ballroom, 3F) |
|---|---|---|
| Chairperson |
Seong Hye Choi (Inha University, Korea) Christopher Chen Li-Hsian (National University of Singapore, Singapore) |
|
| 10:55-11:35 |
The History of Immunotherapy in Alzheimer’s Disease
SangYun Kim (Seoul National University, Korea) |
11:35-12:15 |
Experience of Anti-amyloid β Antibody Therapies for Alzheimer's Disease in Japan
Ken Nagata (Yokohama General Hospital, Japan) |
| May 9 (Fri) 12:15-12:45 |
Luncheon Symposium 1 |
Room A+B (Crystal Ballroom, 3F) |
|---|---|---|
| Chairperson | Hae Ri Na (Bobath Memorial Hospital, Korea) | |
| 12:15-12:30 |
K-AUR and Initial Experience with Lecanemab (Supported by Eisai Korea)
Hyemin Jang (Seoul National University, Korea) |
12:30-12:45 |
Initial Set-up for Lecanemab and Cases in Real-world in Korea (Supported by Eisai Korea)
Sung Hoon Kang (Korea University, Korea) |
| May 10 (Sat) 10:00-12:00 |
Plenary Session 3 *You can also view the Plenary Session 3 in Room C (Emerald Room). |
Room A+B (Crystal Ballroom, 3F) |
|---|---|---|
| Chairperson |
Duk L Na (Happy Mind Clinic, BeauBrain Health Care, Korea) Linda Chiu Wa Lam (The Chinese University of Hong Kong, Hong Kong SAR(China)) |
|
| 10:00-11:00 |
The Australian Dementia Network: Supporting Trials, Registries and Quality Initiatives for Diagnosis and Treatment of Dementia
Christopher Rowe (Austin Health Melbourne, University of Melbourne, Australia) |
11:00-12:00 |
Can We Detect and Treat Alzheimer’s Disease a Decade Before Dementia? (And Why We Must!)
Reisa Sperling (Brigham and Women’s Hospital, USA) |
| May 10 (Sat) 12:00-12:30 |
Luncheon Symposium 3 |
Room A+B (Crystal Ballroom, 3F) |
|---|---|---|
| Chairperson | Jay Cheol Kwon (Changwon Fatima Hospital, Korea) | |
| 12:00-12:15 |
Cerebrolysin in Alzheimer’s Disease: Mechanisms and Therapeutic Efficacy (Supported by DAEWOONG-BIO)
Seunghee Na (The Catholic University of Korea, Korea) |
12:15-12:30 |
Benefits of Choline Alfoscerate Treatment in Patients with Cognitive Impairment (Supported by Chong Kun Dang)
SangHak Yi (Wonkwang University, Korea) |
Sponsored by
